Kura Oncology Inc (KURA)

SG&A Expenses

$31.75M

Quarterly · Period ending: · USD

KURA logo

KURA SG&A Expenses

Latest reported$31.75M
KURA Quarterly SG&A Expenses ($0.00 → $31.75M)
High-resolution chart · PNG

KURA sg&a expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Kura Oncology Inc SG&A Expenses — Quarterly (USD)
Period endingSG&A Expenses (USD)
31,750,000
31,200,000
39,139,000
32,839,000
25,169,000
22,835,000
24,071,000
18,179,000
16,475,000
17,950,000
14,015,000
12,929,000
11,821,000
11,374,000
12,488,000
11,621,000
11,075,000
11,869,000
12,082,000
11,310,000
12,573,000
10,572,000
8,808,000
7,593,000
7,476,000
7,625,000
5,499,000
5,134,000
4,451,000
4,569,000
4,550,000
4,321,000
3,800,000
3,425,000
2,876,000
2,357,000
2,278,000
2,140,000
1,975,000
1,742,000
1,855,000
2,391,000
1,729,000
1,793,000
1,506,000
1,060,000
8,589
63,000
5,242
4,138
7,694
4,475
5,456
4,716
9,475
4,728
4,996
4,241
5,045
5,360
10,104
4,266
7,214
4,238
5,121
3,936
15,613
3,545
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.